Scale-Up and Postapproval Changes in Orally Inhaled Drug Products: Scientific and Regulatory Considerations

Journal of Aerosol Medicine and Pulmonary Drug Delivery · Published 2024-12-09 · DOI 10.1089/jamp.2024.0036

Authors being retrieved — see the publisher record. https://doi.org/10.1089/jamp.2024.0036

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2024

Related articles

• Letter: Respiratory Effectiveness Group Position Statement: Inhaler Choice: Balancing Personalized Health Care and Environmental Responsibility · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2025 · Same journal
• Inhaled Volume as a Digital Biomarker Predicting Outcomes in Chronic Respiratory Disease · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2025 · Same journal
• Effect of Inspiratory Muscle Training on Aerosol Deposition and Pulmonary Perfusion in Post-COVID-19 Syndrome: A Gamma Scintigraphy Study · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2026 · Same journal
• Prospects of Inhalable Formulations of Conventionally Administered Repurposed Drugs for Adjunctive Treatment of Drug-Resistant Tuberculosis: Supporting Evidence from Clinical Trials and Cohort Studies · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2024 · Same journal
• Comparative Efficacy of Two Inhalational Techniques when Using a Pressurized Meter Dose Inhaler with Valved Holding Chamber in Children with Asthma: A Randomized Controlled Trial · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2026 · Same journal
• Lung Deposition of Extrafine Versus Nonextrafine Aerosols at Low Inhalation Flow Rates in Adult Asthma Patients: A Composition Study · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2025 · Same journal
• Multi-Participant Blinded Investigation into Internal Losses of Medication in Commercially Available Mixing Inlets: Testing Different Orally Inhaled Product Classes Following Pharmacopeial Methods · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2025 · Same journal
• Safety and Pharmacokinetic Data for Inhaled Administration of Nintedanib Dry Powder Inhalation for Treatment of Pulmonary Fibrotic Diseases · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2026 · Same journal
• Effect of Replacing Inhalation Devices on Medication Adherence · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2026 · Same journal
• Digital Image Segmentation Analysis Enables High-Throughput Next-Generation Impactor Analysis · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2026 · Same journal